COVID-19: combining antiviral and anti-inflammatory treatments

Lancet Infect Dis. 2020 Apr;20(4):400-402. doi: 10.1016/S1473-3099(20)30132-8. Epub 2020 Feb 27.
No abstract available

Publication types

  • Comment

MeSH terms

  • Anti-Inflammatory Agents
  • Antiviral Agents*
  • Azetidines
  • Betacoronavirus
  • COVID-19
  • Coronavirus Infections / drug therapy
  • Pandemics
  • Pneumonia, Viral
  • SARS-CoV-2
  • Sulfonamides

Substances

  • Anti-Inflammatory Agents
  • Antiviral Agents
  • Azetidines
  • Sulfonamides
  • baricitinib

Supplementary concepts

  • COVID-19 drug treatment